July/August 2026
July/August 2026 | Features
Therapies for IRDs: Moving Beyond Single-Gene Solutions
Emerging gene-agnostic strategies target shared pathways and offer options for IRD patients without mutation-specific therapies.
Aykut Demirkol, MD; Rajvir Solanky; Jayvin Hernandez-Reyes; Ilay Demirkol; and Kuzey Soydas
July/August 2026 | Ocular Oncology
PVRL: When “Uveitis” Is Not Uveitis
A steroid-responsive, uveitis-presenting phenotype was ultimately diagnosed as primary vitreoretinal lymphoma.
Andreas Theocharis, MD; Romy Bejjani, MD; and Erin E. Flynn, MD
Popular Articles
May/June 2026 Supplement | Editorial
The Economics Of Care
Alan Ruby, MD
January/February 2026 Supplement
Introducing ENCELTO Into Retina Practices
David Chin Yee, MD, and Jiong Yan, MD
July/August 2026 | Online Exclusive
Beyond the Conventional: A Modified Yamane Technique
This trimmed haptic solution without glued scleral fixation may be beneficial for patients with bilateral aphakia, microcornea, nystagmus, and vitreous opacity.
Supanji Supanji, MD, MSc, PhD; Dewi Fathin Romdhoniyyah, MD, PhD; Aurelia Priscilla Regita Putri, MD; Hifdza Faza Felisha, MD; Vera Nurohmah Indrawati, S.Si; Ummi Noor Hasanah, S.Kep., Ns; Handayani, S.Kep., Ns; Nurul Imawati, MD; Darmawan M. Sophian, MD; Imam Tiharyo, MD, MSc; Mohammad Nafis Sabirin Mara, MD; Firman Setya Wardhana, MD, MSc; and Muhammad Bayu Sasongko, MD, MEPID, PhD